TRANSFORM-2 Results on Esketamine Published, Along With Caveats - AJMC.com Managed Markets Network

Submitted by Anonymous (not verified) on Tue, 05/21/2019 - 04:07

TRANSFORM-2 Results on Esketamine Published, Along With Caveats  AJMC.com Managed Markets NetworkFull results from TRANSFORM-2, a phase 3 trial that led to the FDA approval in March for esketamine (Spravato), appear Tuesday in the American Journal of ...